Yumanity Therapeutics Stock Price

0.01 (0.92%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 26,344
Bid Price 1.02
Ask Price 1.95
News -
Day High 1.20


52 Week Range


Day Low 1.07
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Yumanity Therapeutics Inc YMTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.92% 1.10 19:20:45
Open Price Low Price High Price Close Price Prev Close
1.12 1.07 1.20 1.10 1.09
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
176 26,344 $ 1.11 $ 29,240 - 0.95 - 16.89
Last Trade Time Type Quantity Stock Price Currency
19:20:04 1 $ 1.06 USD


Draw Mode:

Yumanity Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 11.93M 10.84M 7.22M $ 8.04M $ - -3.85 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -12.67k 9.10%

more financials information »

Yumanity Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical YMTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.151.26991.021.1044,094-0.05-4.35%
1 Month1.121.321.001.1447,438-0.02-1.79%
3 Months1.122.490.951.74450,684-0.02-1.79%
6 Months4.304.400.951.92264,987-3.20-74.42%
1 Year14.2516.890.954.86213,835-13.15-92.28%
3 Years20.0423.470.956.46169,007-18.94-94.51%
5 Years20.0423.470.956.46169,007-18.94-94.51%

Yumanity Therapeutics Description

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Your Recent History
Yumanity T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.